Cell Painting: Fixing Batch Effects for Reliable HCS

Reduce batch effects in Cell Painting. Standardise assays, adopt OME‑Zarr, and apply robust harmonisation to make high‑content screening reproducible.

Cell Painting: Fixing Batch Effects for Reliable HCS
Written by TechnoLynx Published on 23 Sep 2025

Cell Painting at Scale: Fixing Batch Effects for Reliable HCS

Cell Painting now sits at the heart of image‑based profiling, but scale exposes a familiar weak spot: batch effects. Variability in staining, optics, handling and culture conditions can overwhelm true biological signal, causing profiles to cluster by plate or site rather than mechanism (Seal et al., 2024).

The community’s large public resources—most notably the JUMP‑Cell Painting effort—show that shared protocols and reference datasets make results more comparable across organisations (JUMP‑Cell Painting Consortium, n.d.). Yet even with better practice, robust, transparent harmonisation remains essential (Way et al., 2023).

Standardise first

Prevention beats correction. Freeze assay cards (dyes, timings, washes), stabilise microscope settings, log every change, and place biological and technical controls on every plate. Reviews over the last decade emphasise protocol consistency, systematic QC and drift monitoring as the cheapest batch‑effect “fix” (Seal et al., 2024).

Multi‑site projects should borrow from JUMP’s playbook: harmonised labware, plate maps and illumination correction files, piloted jointly and then locked (JUMP‑Cell Painting Consortium, n.d.).

Read more: Explainable Digital Pathology: QC that Scales

Use a modern data layer

High‑content screening produces terabytes of multi‑channel imagery. Legacy containers struggle with I/O, versioning and FAIR access. The OME‑NGFF family—especially OME‑Zarr—addresses these issues with chunked multiscale pyramids and rich metadata, enabling faster training, easier sharing and reproducible analytics (Moore et al., 2023; Moore et al., 2021). Open libraries such as ome‑zarr‑py simplify adoption in Python pipelines (OME, n.d.).

Build a transparent harmonisation workflow

A practical stack has five concise stages: (1) plate‑level QC and illumination correction; (2) consistent feature extraction with frozen versions; (3) per‑plate normalisation anchored to controls; (4) batch correction in embedding space using methods benchmarked for Cell Painting; and (5) drift surveillance with disciplined model lineage (Seal et al., 2024; Way et al., 2023; Moore et al., 2023).

The golden rule is “remove noise, keep biology”: verify that known mechanism‑of‑action clusters persist, negative controls stay tight, and performance generalises to held‑out plates or sites (Seal et al., 2024; Way et al., 2023).

Read more: Edge Imaging for Reliable Cell and Gene Therapy

Show your work

Scientists and reviewers trust pipelines that explain themselves. Present illumination maps, focus heatmaps, per‑plate feature distributions, and UMAPs coloured by batch versus treatment—always with a before/after view and links to the exact settings used (Moore et al., 2023; Moore et al., 2021). Bind QC and correction artefacts to each dataset so audits and re‑analysis are straightforward.

Measure what matters

A small, decision‑ready KPI set suffices: batch separability (down), mechanism‑of‑action clustering (up), cross‑site retrieval (up), and replicate rank stability for hit triage (up). Tie thresholds to go/no‑go decisions so teams move on evidence, not debate (Seal et al., 2024).

Read more: Validation‑Ready AI for GxP Operations in Pharma

Roll out without disruption



Start with one use case (e.g., MoA annotation plates). Convert to OME‑Zarr, run standard QC, extract a reference embedding, trial two or three batch‑correction methods from the latest benchmarks, and pick the option that reduces batch signal while preserving biology. Run a live, side‑by‑side comparison for a month; if triage reliability improves, lock versions and scale by plate count, site and assay (Way et al., 2023; Moore et al., 2023).


Read more: AI in Life Sciences

How TechnoLynx can help

TechnoLynx delivers validation‑ready Cell Painting pipelines that standardise acquisition, QC and analytics across sites. We convert data to OME‑Zarr, implement plate‑level QC and illumination correction, and deploy harmonisation methods benchmarked on public datasets. Our dashboards make drift, corrections and outcomes explainable; our versioned builds keep runs reproducible; and our process ensures that biology—not batch—drives decisions (Moore et al., 2023; Way et al., 2023).

References

  • JUMP‑Cell Painting Consortium (n.d.) JUMP‑Cell Painting Hub. Available at: https://jump-cellpainting.broadinstitute.org/ (Accessed: 19 September 2025).

  • Moore, J. et al. (2021) ‘OME‑NGFF: a next‑generation file format for expanding bioimaging data‑access strategies’, Nature Methods. Available at: https://www.nature.com/articles/s41592-021-01326-w.pdf (Accessed: 19 September 2025).

  • Moore, J. et al. (2023) ‘OME‑Zarr: a cloud‑optimised bioimaging file format with international community support’, Histochemistry and Cell Biology, 160, pp. 223–251. Available at: https://link.springer.com/article/10.1007/s00418-023-02209-1 (Accessed: 19 September 2025).

  • OME (n.d.) ome‑zarr‑py. Available at: https://github.com/ome/ome-zarr-py (Accessed: 19 September 2025).

  • Seal, S. et al. (2024) ‘Cell Painting: a decade of discovery and innovation in cellular imaging’, Nature Methods. Available at: https://www.nature.com/articles/s41592-024-02528-8.pdf (Accessed: 19 September 2025).

  • Way, G.P. et al. (2023) ‘Evaluating batch correction methods for image‑based cell profiling’, bioRxiv preprint. Available at: https://www.biorxiv.org/content/10.1101/2023.09.15.558001v3.full.pdf (Accessed: 19 September 2025).

  • Image credits: Freepik

Visual Computing in Life Sciences: Real-Time Insights

Visual Computing in Life Sciences: Real-Time Insights

6/11/2025

Learn how visual computing transforms life sciences with real-time analysis, improving research, diagnostics, and decision-making for faster, accurate outcomes.

AI-Driven Aseptic Operations: Eliminating Contamination

AI-Driven Aseptic Operations: Eliminating Contamination

21/10/2025

Learn how AI-driven aseptic operations help pharmaceutical manufacturers reduce contamination, improve risk assessment, and meet FDA standards for safe, sterile products.

AI Visual Quality Control: Assuring Safe Pharma Packaging

AI Visual Quality Control: Assuring Safe Pharma Packaging

20/10/2025

See how AI-powered visual quality control ensures safe, compliant, and high-quality pharmaceutical packaging across a wide range of products.

AI for Reliable and Efficient Pharmaceutical Manufacturing

AI for Reliable and Efficient Pharmaceutical Manufacturing

15/10/2025

See how AI and generative AI help pharmaceutical companies optimise manufacturing processes, improve product quality, and ensure safety and efficacy.

Barcodes in Pharma: From DSCSA to FMD in Practice

Barcodes in Pharma: From DSCSA to FMD in Practice

25/09/2025

What the 2‑D barcode and seal on your medicine mean, how pharmacists scan packs, and why these checks stop fake medicines reaching you.

Pharma’s EU AI Act Playbook: GxP‑Ready Steps

Pharma’s EU AI Act Playbook: GxP‑Ready Steps

24/09/2025

A clear, GxP‑ready guide to the EU AI Act for pharma and medical devices: risk tiers, GPAI, codes of practice, governance, and audit‑ready execution.

Explainable Digital Pathology: QC that Scales

Explainable Digital Pathology: QC that Scales

22/09/2025

Raise slide quality and trust in AI for digital pathology with robust WSI validation, automated QC, and explainable outputs that fit clinical workflows.

Validation‑Ready AI for GxP Operations in Pharma

Validation‑Ready AI for GxP Operations in Pharma

19/09/2025

Make AI systems validation‑ready across GxP. GMP, GCP and GLP. Build secure, audit‑ready workflows for data integrity, manufacturing and clinical trials.

Edge Imaging for Reliable Cell and Gene Therapy

Edge Imaging for Reliable Cell and Gene Therapy

17/09/2025

Edge imaging transforms cell & gene therapy manufacturing with real‑time monitoring, risk‑based control and Annex 1 compliance for safer, faster production.

AI in Genetic Variant Interpretation: From Data to Meaning

AI in Genetic Variant Interpretation: From Data to Meaning

15/09/2025

AI enhances genetic variant interpretation by analysing DNA sequences, de novo variants, and complex patterns in the human genome for clinical precision.

AI Visual Inspection for Sterile Injectables

AI Visual Inspection for Sterile Injectables

11/09/2025

Improve quality and safety in sterile injectable manufacturing with AI‑driven visual inspection, real‑time control and cost‑effective compliance.

Predicting Clinical Trial Risks with AI in Real Time

Predicting Clinical Trial Risks with AI in Real Time

5/09/2025

AI helps pharma teams predict clinical trial risks, side effects, and deviations in real time, improving decisions and protecting human subjects.

Generative AI in Pharma: Compliance and Innovation

1/09/2025

Generative AI transforms pharma by streamlining compliance, drug discovery, and documentation with AI models, GANs, and synthetic training data for safer innovation.

AI for Pharma Compliance: Smarter Quality, Safer Trials

27/08/2025

AI helps pharma teams improve compliance, reduce risk, and manage quality in clinical trials and manufacturing with real-time insights.

Markov Chains in Generative AI Explained

31/03/2025

Discover how Markov chains power Generative AI models, from text generation to computer vision and AR/VR/XR. Explore real-world applications!

Augmented Reality Entertainment: Real-Time Digital Fun

28/03/2025

See how augmented reality entertainment is changing film, gaming, and live events with digital elements, AR apps, and real-time interactive experiences.

Case Study: WebSDK Client-Side ML Inference Optimisation

20/11/2024

Browser-deployed face quality classifier rebuilt around a single multiclassifier, WebGL pixel capture, and explicit device-capability gating.

Why do we need GPU in AI?

16/07/2024

Discover why GPUs are essential in AI. Learn about their role in machine learning, neural networks, and deep learning projects.

Retrieval Augmented Generation (RAG): Examples and Guidance

23/04/2024

Learn about Retrieval Augmented Generation (RAG), a powerful approach in natural language processing that combines information retrieval and generative AI.

AI in drug discovery

22/06/2023

A new groundbreaking model developed by researchers at the MIT utilizes machine learning and AI to accelerate the drug discovery process.

Case-Study: Performance Modelling of AI Inference on GPUs

15/05/2023

How TechnoLynx modelled AI inference performance across GPU architectures — delivering two tools (topology-level performance predictor and OpenCL GPU characteriser) plus engineering education that changed how the client's team thinks about GPU cost.

3 Ways How AI-as-a-Service Burns You Bad

4/05/2023

Listen what our CEO has to say about the limitations of AI-as-a-Service.

Consulting: AI for Personal Training Case Study - Kineon

2/11/2022

TechnoLynx partnered with Kineon to design an AI-powered personal training concept, combining biosensors, machine learning, and personalised workouts to support fitness goals and personal training certification paths.

Back See Blogs
arrow icon